Panion
  • Home
  • Our Story
    • History
    • Company
    • Management and Board
    • Advisory Board
    • Panion US
  • Science
    • Epilepsy in dogs
    • About Gene therapy
    • About NPY and AAV vectors
    • Patents and licences
  • Projects
    • Epilepsy
    • Other projects
  • News
    • Newsletter
  • Panion US
  • Investor relations
Select Page

The Board of Directors proposes that subsidiary is distributed to the shareholders

Feb 5, 2016

Read more >> (Only in swedish) Recent Posts Påminnelse angående budet från CombiGene 17 June, 2019 Panion Animal Health emitterar nya aktier 7 June, 2019 Final report from dog safety study released 29 May, 2019 CombiGene AB (publ) har publicerat erbjudandehandling...

Archives

  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • July 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • June 2016
  • May 2016
  • February 2016
  • August 2015
  • July 2015

Panion Animal Health AB

org. nr. 559018-4171

Anja E. H. Holm
+45 22 94 66 00
info@panion-animalhealth.com

Linked in

Twitter

Newsletter

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Read more